Non-paraneoplastic sensory ganglionopathy

Non-paraneoplastic sensory ganglionopathy (also known as non-paraneoplastic sensory neuronopathy) is a rare neurological disorder characterized by damage to the sensory neurons in the dorsal root ganglia (DRG) that is not associated with an underlying malignancy. Unlike paraneoplastic forms, which occur as a remote effect of cancer (often linked to anti-Hu antibodies), non-paraneoplastic sensory ganglionopathy arises from other causes, including autoimmune mechanisms (such as Sjögren syndrome), toxic exposures (e.g., pyridoxine toxicity, cisplatin), or may be idiopathic with no identifiable cause. The condition primarily affects the peripheral sensory nervous system. Because the cell bodies of sensory neurons in the dorsal root ganglia are directly damaged, the pattern of sensory loss is typically asymmetric, non-length-dependent, and can affect both proximal and distal regions. Key symptoms include sensory ataxia (impaired coordination due to loss of proprioception), widespread numbness, painful paresthesias, and pseudoathetoid movements of the hands. Patients often experience significant gait instability and difficulty with fine motor tasks due to the loss of deep sensation. All sensory modalities may be affected, but large-fiber functions (vibration and joint position sense) are often disproportionately impaired. There is no curative treatment for non-paraneoplastic sensory ganglionopathy. Management focuses on identifying and treating any underlying cause (such as immunosuppressive therapy for autoimmune-associated forms), symptomatic relief of neuropathic pain with medications such as gabapentin, pregabalin, or duloxetine, and rehabilitation strategies including physical and occupational therapy to improve balance and functional independence. In idiopathic cases, immunomodulatory treatments such as intravenous immunoglobulin (IVIg) or corticosteroids have been tried with variable success. The prognosis depends on the underlying etiology, but neuronal loss in the dorsal root ganglia is often irreversible, making early diagnosis and intervention important.

Common questions about Non-paraneoplastic sensory ganglionopathy